Navigation Links
22 of America's most promising scientists selected as 2011 Pew Scholars in the Biomedical Sciences
Date:6/13/2011

Twenty-two of America's most promising scientists have been named Pew Scholars in the Biomedical Sciences by The Pew Charitable Trusts. The 2011 Pew Scholars will join a select community that includes MacArthur Fellows, recipients of the Albert Lasker Medical Research Award and three Nobel Prize winners. Research by the new class of Scholars is related to many human diseases ranging from Alzheimer's to diabetes to ocular degeneration. The program encourages early-career scientists to advance research that leads to important medical breakthroughs and treatments.

"Pew is pleased to provide this country's most ambitious and dedicated scientists with timely funding that enables them to explore novel areas of investigation early in their careers, at what may be the most inventive and creative period in their research," said Rebecca W. Rimel, president and CEO of The Pew Charitable Trusts.

To date, the program has invested more than $125 million to fund over 500 scholars. It is a rigorously competitive program where recipients receive $240,000 over four years to pursue their research without restriction. Applicants who work in all areas of physical and life sciences related to biomedical study must be nominated by an invited institution and demonstrate both excellence and innovation in their research. This year, 175 institutions were requested to nominate a candidate and 136 eligible nominations were received.

"Early recognition of young scientists with ideas that challenge their fields is essential for the vitality of the biomedical sciences," said Craig C. Mello, Ph.D., a 1995 Pew Scholar, a 2006 Nobel Laureate in Physiology or Medicine and the chair of the national advisory committee for the program. "From my own experience as a Pew Scholar and member of the advisory board, this program gives young scientists the confidence to pursue risky projects, and to push the boundaries of their fields, planting the seeds for major scientific advancements. I welcome these promising scientists into the Pew Biomedical Scholars family and look forward to watching as their research unfolds in the years ahead."

The new 2011 Pew Scholars are:

  • Christine M. Dunham, Ph.D.
    Emory University School of Medicine
    Structural Biology and Pathogenesis

  • Thomas G. Fazzio, Ph.D.
    University of Massachusetts Medical School
    Stem Cell Biology

  • Max L. Fletcher, Ph.D.
    University of Tennessee Health Science Center
    Neuroscience

  • Hunter B. Fraser, Ph.D.
    Stanford University
    Gene Regulation

  • Melissa K. Gardner, Ph.D.
    University of Minnesota
    Cell Biology and Biophysics

  • Mary Gehring, Ph.D.
    Whitehead Institute for Biomedical Research
    Gene Regulation and Epigenetics

  • Jeff Gore, Ph.D.
    Massachusetts Institute of Technology
    Biophysics and Systems Biology

  • Takaki Komiyama, Ph.D.
    University of California, San Diego
    Neuroscience

  • Mei Kong, Ph.D.
    Beckman Institute, City of Hope
    Cancer Cell Biology

  • Michael S. Kuhns, Ph.D.
    University of Arizona
    Immunology

  • Erica Larschan, Ph.D.
    Brown University
    Epigenetics

  • Eros Lazzerini Denchi, Ph.D.
    Scripps Research Institute
    Aging and Stem Cell Biology

  • Ann C. Morris, Ph.D.
    University of Kentucky
    Developmental Neurobiology and Genetics

  • James B. Moseley, Ph.D.
    Dartmouth Medical School
    Cell Biology

  • Suzanne M. Nobel, M.D., Ph.D.
    University of California, San Francisco
    Fungal Pathogenesis

  • Brad J. Nolen, Ph.D.
    University of Oregon
    Structural Biology

  • Chad G. Pearson, Ph.D.
    University of Colorado, Denver
    Cell Biology

  • Sharad Ramanathan, Ph.D.
    Harvard University
    Neuroscience and Systems Biology

  • Anthony R. Richardson, Ph.D.
    University of North Carolina at Chapel Hill
    Microbiology and Immunology

  • Niels Ringstad, Ph.D.
    New York University School of Medicine
    Neuroscience

  • Georgios Skiniotis, Ph.D.
    University of Michigan
    Structural Biology and Membrane Biology

  • Liang Zhou, M.D., Ph.D.
    Northwestern University
    Immunology and Gene Regulation


'/>"/>

Contact: Jayne Miller
jmiller@pewtrusts.org
202-540-6548
Pew Health Group
Source:Eurekalert

Related biology news :

1. 2010 Meeting of the Americas, Brazil: News media registration open
2. Brandeis study shows economic impact of dengue virus in Americas
3. UCR researchers propose minocycline as a promising drug for patients with Fragile X syndrome
4. Researchers identify promising gene target for neuroblastoma therapy
5. Promising new drug being evaluated as possible treatment option for fragile X syndrome
6. Landscape-scale treatment promising for slowing beetle spread
7. Research uncovers promising target to treat chronic abdominal pain
8. Promising 3-year data: Saving limbs with drug-eluting stents
9. Therapeutic hypothermia is promising strategy to minimize tissue damage
10. UC Davis bench-to-bedside research: Promising treatment in clinical trials
11. Promising device snags young inventors coveted spot at IShow
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology: